CORC

在结果中检索

CORC

浏览/检索结果: 共612条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
The performance of the LHAASO-KM2A tested by the cosmic-ray Moon shadow 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Nan, Yuncheng;  Li, Zhe;  Chen, Songzhan;  Feng, Cunfeng;  Wu, Sha
收藏  |  浏览/下载：11/0  |  提交时间：2023/01/16
Measurement of interplanetary magnetic field in short period using the cosmic-ray Sun shadow measured by LHAASO 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Nan, Yuncheng;  Chen, Songzhan;  Feng, Cunfeng;  Cao, Zhen;  Aharonian, F.
收藏  |  浏览/下载：12/0  |  提交时间：2023/01/23
Measurement of very-high-energy diffuse gamma-ray emission from Galactic plane with LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Zhang, Rui;  Zhao, Shiping;  Zhang, Yi;  Yuan, Qiang;  Cao, Zhen
收藏  |  浏览/下载：17/0  |  提交时间：2023/01/23
Observations of extended very-high-energy halos around Geminga and Monogem with the LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Guo, Yingying;  Zhang, Yi;  Yuan, Qiang;  Hu, Hongbo;  Cao, Zhen
收藏  |  浏览/下载：19/0  |  提交时间：2023/01/23
Design and Verification of Anti-radiation SPI Interface in Dual Mode Satellite Navigation Receiver Baseband Chip 会议论文
International Conference on Communications, Signal Processing, and Systems, CSPS 2018, Dalian, China, 2018-07-14
作者:  Yin, Yi Ran;  Zhang, Xiao Lin
收藏  |  浏览/下载：61/0  |  提交时间：2019/12/30
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
Sulfide Stress Corrosion Cracking Behavior of G105 and S135 High-Strength Drill Pipe Steels in H2S Environment 会议论文
作者:  Luo, Sheji;  Liu, Ming;  Shen, Yi;  Lin, Xiuzhou
收藏  |  浏览/下载：15/0  |  提交时间：2019/11/19
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace